Evidence map›Paper›PMID 34506794›Full record

ReviewChest2022

Focused Management of Patients With Severe Acute Brain Injury and ARDS.

Jennifer A Kim, Sarah Wahlster, Jamie Nicole LaBuzetta, Christa O'Hana S Nobleza, Nicholas J Johnson, Clio Rubinos, Deepa Malaiyandi, Kristine H O'Phelan, Shraddha Mainali, Aarti Sarwal and 1 more

Open access · bronzeAbstract readReview
In one paragraph

Review in Chest, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 16 papers.

0numbers the graph read from it
0cells of the map it votes in
16citing papers in PubMed
2.8field-weighted citation impact, top 8% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

16 citing papers in PubMed, 27 citations in OpenAlex.

  1. Trial
  2. Review
  3. Article
  4. Review
  5. Article
  6. Article
  7. Review
  8. Review
  9. Article
  10. Article
  11. Article
  12. Review
  13. Article
  14. Observational
  15. Review
  16. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors at 10 institutions in 1 country.

Jennifer A KimDepartment of Neurology, Yale University, New Haven, CT. Electronic address: Jennifer.a.kim@yale.edu.
Sarah WahlsterDepartments of Neurology and Neurological Surgery, University of Washington, Seattle, WA.
Jamie Nicole LaBuzettaDepartment of Neurosciences, Division of Neurocritical Care, University of California-San Diego, San Diego, CA.
Christa O'Hana S NoblezaDepartment of Neurology, Baptist Memorial Health Center, Memphis, TN.
Nicholas J JohnsonDepartment of Emergency Medicine and Division of Pulmonary, Critical Care, and Sleep Medicine, University of Washington, Seattle, WA.
Clio RubinosDepartment of Neurology, Division of Epilepsy and Neurocritical Care, University of North Carolina School of Medicine, Chapel Hill, NC.
Deepa MalaiyandiDepartment of Neurology, Division of Neurocritical Care, University of Toledo College of Medicine, Toledo, OH.
Kristine H O'PhelanDepartment of Neurology, University of Miami, Miami, FL.
Shraddha MainaliDepartment of Neurology, Virginia Commonwealth University, Richmond, VA.
Aarti SarwalDepartment of Neurology, Wake Forest University, Winston Salem, NC.
Emily J GilmoreDepartment of Neurology, Yale University, New Haven, CT.
Yale University · USBaptist Memorial Health Care · USNeurological Surgery · USUniversity of California, San Diego · USUniversity of Miami · USUniversity of North Carolina at Chapel Hill · USUniversity of Toledo · USUniversity of Washington · USVirginia Commonwealth University · USWake Forest University · US

Funding

Yale Clinical and Translational Science Award (U Component)UL1TR001863 · NCATS · YALE UNIVERSITY · PI John H. Krystal, LUCILA OHNO-MACHADO · 2016 to 2026
$102.9M
The OSU Center for Clinical and Translational Science: Advancing Today's Discoveries to Improve HealthUL1TR002733 · NCATS · OHIO STATE UNIVERSITY · PI RINGEL, MATTHEW D · 2018 to 2022
$28.9M
NCATS NIH HHS UL1 TR001863NCATS NIH HHS UL1 TR002733
6 · The paper itself

Abstract

Considering the COVID-19 pandemic where concomitant occurrence of ARDS and severe acute brain injury (sABI) has increasingly coemerged, we synthesize existing data regarding the simultaneous management of both conditions. Our aim is to provide readers with fundamental principles and concepts for the management of sABI and ARDS, and highlight challenges and conflicts encountered while managing concurrent disease. Up to 40% of patients with sABI can develop ARDS. Although there are trials and guidelines to support the mainstays of treatment for ARDS and sABI independently, guidance on concomitant management is limited. Treatment strategies aimed at managing severe ARDS may at times conflict with the management of sABI. In this narrative review, we discuss the physiological basis and risks involved during simultaneous management of ARDS and sABI, summarize evidence for treatment decisions, and demonstrate these principles using hypothetical case scenarios. Use of invasive or noninvasive monitoring to assess brain and lung physiology may facilitate goal-directed treatment strategies with the potential to improve outcome. Understanding the pathophysiology and key treatment concepts for comanagement of these conditions is critical to optimizing care in this high-acuity patient population.

Indexed as

Disease ManagementBrain InjuriesCOVID-19HumansRespiratory Distress SyndromeSARS-CoV-2acute brain injuryARDSintensive careintracranial hypertension

Identifiers

PMID34506794
PMCPMC8423666
OpenAlexW3196445636

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.